Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022
Thu, June 2, 2022
Wed, June 1, 2022
Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022
Thu, May 26, 2022

Oren Livnat Maintained (VRCA) at Strong Buy with Decreased Target to $12 on, May 31st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-12-on-may-31st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $20 to $12 on, May 31st, 2022.

Oren has made no other calls on VRCA in the last 4 months.



There are 3 other peers that have a rating on VRCA. Out of the 3 peers that are also analyzing VRCA, 1 agrees with Oren's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Daniel Busby of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $4 on, Wednesday, May 25th, 2022


These are the ratings of the 2 analyists that currently disagree with Oren


  • Kemp Dolliver of "Brookline Capital" Initiated at Strong Buy and Held Target at $20 on, Thursday, March 10th, 2022
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, March 3rd, 2022

Publication Contributing Sources